Kim P. Kamdar is Director at Singular Genomics Systems, Inc. (OMIC). They have made 8 open-market trades across 3 companies since 2016, most recently 2026-07-10.
CIK 0001535065
5 open-market purchases totalling $477K since 2016, against 3 sales. Across 5 scored buys the stock is down 32.5% at ninety days, and 35.3 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 0% | 0% |
| Avg Move | -6.0% | -18.3% | -32.5% |
| Alpha | -5.2% | -20.1% | -35.3% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EVFM | SELL | 2023-12-21 | 2023-12-22 | $0.62 | $6 | +0.0% | +0.0% | +0.0% |
| OMIC | SELL | 2023-08-11 | 2023-08-15 | $0.58 | $575K | -13.0% | -22.8% | -35.2% |
| EVFM | BUY | 2021-06-18 | 2021-06-21 | $1.17 | $12K | -3.5% | -14.7% | -31.4% |
| EVFM | BUY | 2020-06-12 | 2020-06-16 | $2.94 | $15K | -5.6% | -2.3% | -23.2% |
| OBLN | BUY | 2019-08-06 | 2019-08-08 | $4.00 | $50K | -26.8% | -45.2% | -41.4% |
| EVFM | SELL | 2019-05-21 | 2019-05-23 | $5.07 | $3K | +15.9% | +27.8% | -4.0% |
| OBLN | BUY | 2018-08-23 | 2018-08-27 | $1.82 | $200K | +0.3% | -16.1% | -40.3% |
| OBLN | BUY | 2016-10-12 | 2016-10-14 | $15.00 | $201K | +5.7% | -13.4% | -26.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.